|  CEO Jeongbok Park “Empowering innovative game development”

We specialize in driving growth at scale through growth and technological innovation, as evidenced by MedPark.

MedPark provides a variety of integrated regenerative medicine solutions for bone, skin, collagen, and human soft tissue, contributing to various fields that require regeneration in the human body.

According to the Financial Supervisory Service's electronic disclosure system on the 14th, MedPark's sales in the first half of the year increased 47% compared to the same period last year.

During the same period, operating profit and net profit also realized surplus, continuing to expand and maintain surplus in terms of sales and profitability in the second quarter
following the first quarter of this year. In addition, MedPark expects to achieve a sales increase of approximately 300% in the second half of the year compared to the same period last year. 

[Source=MedPark] 

This is due to increased sales and business expansion in the medical market, expanding the business portfolio strategy to all fields of regenerative medicine based on biomaterials,
including Europe, The company explains that it is confirmed that this is due to the development and discovery of business partners through various marketing and academic
conferences based on a global branding strategy in overseas markets such as the United States and the Middle East.

As investment in physical and human facilities infrastructure over several years is expected to lead to full-scale sales expansion, the financial structure is expected to improve significantly through profit realization through improved profitability.
MedPark CEO Jeong-bok Park said, “Based on the value of prioritizing the happiness of the family through the health and recovery of patients, we will continue to strive to develop innovative regenerative solutions.”
A MedPark official said, “We plan to gradually strengthen our competitiveness in this field by focusing on research and development and investment in the future.
Based on this, the somewhat delayed IPO plan will be pushed forward in earnest, and next year’s listing plan is expected to become visible,” he explained.

Source: News Inside
https://www.newsinside.kr/news/articleView.html?idxno=2503930 

- Kdpress
http://www.kdpress.co.kr/news/articleView.html?idxno=131079

- Enet News
https://www.enetnews.co.kr/news/articleView.html?idxno=28147

- Wemake News
https://wemakenews.co.kr/news/view.php?no=19762

- Dental News
http://www.doctorstimes.com/news/articleView.html?idxno=228554